Tag: immune evasion in cancer

In the ever-evolving landscape of oncology, the search for effective therapeutic strategies against relapsed and refractory non-Hodgkin lymphoma (NHL) remains ...

In the relentless pursuit of effective cancer therapies, novel research has emerged, casting fresh light on the metabolic processes within ...

Unveiling the Complex Dance of Tumor Dormancy and Relapse in Cancer Research Cancer remains one of the most formidable health ...

In a groundbreaking advancement poised to reshape the landscape of cancer therapeutics, researchers have unveiled compelling evidence that chrysin—a naturally ...

In a groundbreaking study poised to reshape our understanding of colorectal cancer metastasis, a team of researchers has unveiled a ...

A revolutionary advancement in cancer treatment is on the horizon as scientists at King’s College London have developed a novel ...

In a groundbreaking advancement for cancer immunotherapy, recent research has spotlighted TIGIT as a promising immune checkpoint target specifically relevant ...

A groundbreaking study recently published in BMC Cancer has revealed a promising advancement in the treatment of human papillomavirus-positive (HPV⁺) ...

Cancer-associated fibroblasts (CAFs) have long been recognized as pivotal yet perplexing components within the tumor microenvironment, influencing cancer progression and ...

B cells, traditionally celebrated for their role in antibody production, have emerged as pivotal players within the tumor microenvironment (TME), ...